Identification of Distinct Disease Activity Trajectories in Methotrexate‐Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty‐Four Months-Reference-Cited by-同舟云学术

Identification of Distinct Disease Activity Trajectories in Methotrexate‐Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty‐Four Months

Published:2021-12-30 Issue:1 Volume:74 Page:131-141
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Bykerk Vivian P.¹^ORCID,Lee Eun Bong²^ORCID,Vollenhoven Ronald³,Gruben David C.⁴,Fallon Lara⁵,Woolcott John C.⁶,Keystone Edward⁷^ORCID

Affiliation:

1. Weill Cornell Medical College New York New York

2. Seoul National University College of Medicine Seoul Republic of Korea

3. Amsterdam University Medical Centres Amsterdam The Netherlands

4. Pfizer Inc Groton Connecticut

5. Pfizer Canada Montreal Quebec Canada

6. Pfizer Inc Collegeville Pennsylvania

7. Mount Sinai Hospital Toronto Ontario Canada

Funder

Pfizer

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24709

Reference39 articles.

1. Review of treatment response in rheumatoid arthritis: assessment of heterogeneity

2. Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH)

3. Distinct Trajectories of Disease Activity Over the First Year in Early Rheumatoid Arthritis Patients Following a Treat-to-Target Strategy

4. Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

5. Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study;Rheumatology International;2023-10-10

2. Heterogeneity of treatment responses in rheumatoid arthritis using group based trajectory models: secondary analysis of clinical trial data;BMC Rheumatology;2023-09-25

3. JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases;International Journal of Molecular Sciences;2023-06-17

4. Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis;Arthritis Research & Therapy;2022-10-14